Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000974711 | SCV001122555 | likely benign | Agammaglobulinemia 2, autosomal recessive | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV000974711 | SCV002495797 | uncertain significance | Agammaglobulinemia 2, autosomal recessive | 2021-06-21 | criteria provided, single submitter | clinical testing | IGLL1 NM_020070.3 exon 3 p.Thr117Ile (c.350C>T): This variant has been reported in the literature in at least 3 individuals with progressive multifocal leukoencephalopathy as a potential risk allele for this condition (Eis 2020 PMID:32256442). _x000D_ This variant is present in 0.5% (208/41446) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/22-23573558-G-A?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:791698). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Laboratory of Diagnostic Genome Analysis, |
RCV001572741 | SCV001797568 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001572741 | SCV001966041 | uncertain significance | not provided | no assertion criteria provided | clinical testing |